Verition Fund Management
AVEO

Verition Fund Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Verition Fund Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,489
Closed -$84K – 2367
2021
Q1 		$84K Buy
+11,489
New +$99.1K ﹤0.01% 1447
2018
Q2 		– Sell
-4,212
Closed -$122K – 1442
2018
Q1 		$122K Buy
+4,212
New +$123K 0.01% 1047

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Verition Fund Management's AVEO Position: Q2 2021 in Review

Verition Fund Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 11,489 shares — an estimated $84K sold.

Verition Fund Management first reported a position in AVEO in Q1 2018 and held it in 2 quarters. The position peaked at $122K in Q1 2018. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

  • Verition Fund Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Verition Fund Management sold 11,489 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $84K.
  • Verition Fund Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 2 quarters.
  • Verition Fund Management's AVEO Pharmaceuticals, Inc. position peaked at $122K in Q1 2018.
  • 63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on Verition Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.